StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.25−0.03 (-9.88%)

Close on Nov 18, 2026Market cap $5.50MP/E –Yield –

Soligenix price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Soligenix's price to sales ratio was 41.5× on Apr 30, 2025, against 4.8× a year earlier. Over the last 5 years it ranged from 1.8× to 48.7×, with a median of 14.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 202541.5×+24.5
2024Dec 31, 202417.0×+8.8
2023Dec 29, 20238.2×−14.4
2022Dec 30, 202222.6×−9.8
2021Dec 31, 202132.4×+24.1
2020Dec 31, 20208.3×+3.2
2019Dec 31, 20195.0×+2.3
2018Dec 31, 20182.8×+0.5
2017Dec 29, 20172.3×+1.5
2016Dec 30, 20160.7×−3.2
2015Dec 31, 20154.0×+0.6
2014Dec 31, 20143.3×−9.7
2013Dec 31, 201313.0×+12.1
2012Dec 31, 20120.9×−67.2
2011Dec 30, 201168.1×–

More Soligenix figures

See a number that looks wrong?